This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Jackson Laboratory. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Javad Noorbakhsh: Innovator in Cancer Classification Technology
Introduction
Javad Noorbakhsh is a prominent inventor based in Cambridge, MA, specializing in advanced technologies for cancer classification. His innovative work focuses on utilizing deep learning models to enhance the accuracy of cancer diagnosis through histopathological image analysis.
Latest Patents
Noorbakhsh holds a patent for "Convolutional neural networks for classification of cancer histological images." This patent describes techniques for classifying histopathological whole slide images (WSIs) as either cancerous or non-cancerous tissue. The technology also distinguishes between cancerous tissues with genetic mutations and those without. The system employs a processor configured to implement a container-based processing architecture, enabling the training and application of a deep learning model for effective image classification. In certain applications, treatment options may be selected based on the classification results derived from this model.
Career Highlights
Javad Noorbakhsh is affiliated with The Jackson Laboratory, where he contributes to groundbreaking research in cancer biology and computational methods. His work is pivotal in bridging the gap between technology and healthcare, particularly in the realm of cancer diagnostics.
Collaborations
Noorbakhsh collaborates with esteemed colleagues, including Jeffrey Hsu-Min Chuang and Ali Foroughi Pour, who share his commitment to advancing cancer research through innovative technological solutions.
Conclusion
Javad Noorbakhsh's contributions to the field of cancer classification through deep learning exemplify the intersection of technology and medicine. His work not only enhances diagnostic accuracy but also paves the way for personalized treatment approaches in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
